Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name CCAT2
   Synonyms CCAT2, LINC00873, NCCP1
   Region GRCh38_8:127400399-127402150    Sequence
   Ensembl ENSG00000280997
   RefSeq NR_109834
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name cholangiocarcinoma
   ICD-0-3  M810/3
   Methods qPCR, Western blot, in vitro knockdown etc.
   Sample cell lines (RBE, HCCC-9810, QBC939, CCLP-1, Huh-28, HuCCT1, KMBC, HIBEC), CCA tissue
   Expression Pattern up-regulated
   Function Description

The potential effects of CCAT2 in CCA cells was evaluated in vitro including cell proliferation, colony-forming ability, apoptosis, migration, invasion and epithelial-to-mesenchymal transition (EMT). CCAT2 was aberrantly overexpressed in CCA tissue samples and cells, and this upregulation was correlated with tumor size, lymph node invasion, TNM stage and postoperative recurrence in CCA patients. Overexpression of CCAT2 was a dismal prognostic indicator for patients with CCA. Furthermore, CCAT2 silencing caused tumor suppressive effects via reducing cell proliferation, migration and invasion, inducing cell apoptosis and reversing the EMT process in HuCCT1 and CCLP1 cells.

   Pubmed ID 29329034
   Year 2018
   Title Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
   External Links
   Links for  CCAT2 GenBank       HGNC       lncrnadb       Noncode
   Links for  cholangiocarcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.